Northwestern Medicine: 3rd Annual Advances in Pulmonary Hypertension
Avatar

Diagnosis and Management of Pulmonary Hypertension with HFpEF

By Northwestern Medicine: 3rd Annual Advances in Pulmonary Hypertension FEATURING Sanjiv J. Shah
October 15, 2018
0 Comments
Login to view comments. Click here to Login

Featured Video

13:50
Cardiac Contractility Modulation

AHA 2020 - Classifying Heart Failure Using NYHA Functional Class Assessment

Feat. W. Abraham

Related Content

AUTOPLAY
Houston Methodist DeBakey Heart and Vascular Center

5th Annual Cardiology for the Non-Cardiologist

Sat, May 22, 2021
MUSC Cardiology

Charleston HFpEF Virtual Conference: The Latest Knowledge on Heart Failure…

Fri, Apr 16, 2021
Courage and Innovation Symposium: Heart Failure & Heart Transplantation

Courage and Innovation Symposium: Heart Failure & Heart Transplantation (C…

Sat, Mar 6, 2021
Heart Failure 2021: An Update on Therapy

Heart Failure 2021: An Update on Therapy

Fri, Mar 12, 2021
16:54
Cardiac Contractility Modulation

Cardiac Contractility Modulation: How it Works

Feat. J. Ehrlich, H. Levin
62:50
Cardiac Contractility Modulation

Failure Is not an Option! Implementing CCM into your Practice

Feat. F. Syed, M. Goldschmidt, I. Rao
25:31
Novartis

The War on Heart Failure

Feat. E. Braunwald
64:40
Cardiac Contractility Modulation

CCM® Therapy - Mechanism of Action, Patient Selection and Identification

Feat. A. Kaplan, H. Saltzman
88:01
Cardiac Contractility Modulation

The Comparison and Advantages of the Use of Device Therapy in Heart Failur…

Feat. V. Thohan, G. Tomassoni, R. Doshi, F. Abi-Samra, I. Rao
61:12
Cardiac Contractility Modulation

Assessing Heart Failure Patients - Where Does CCM® Therapy Fit

Feat. S. Brune, N. Bonnet, M. Arnold
33:38
Cardiac Contractility Modulation

AAHFN Advanced 2020 - CCM® in HF - Mechanism and Clinical Evidence

Feat. R. Kahwash, N. Albert
14:44
26th Annual San Diego Heart Failure Symposium

Broadening Indications for the Use of Angiotensin Receptor Neprilysin Inhi…

Feat. C. Yancy
15:40
Advanced Lung Disease Conference 2020

PAH Management: When to Consider Monotherapy? What Is the Efficacy of Doub…

Feat. S. Sahay
14:16
Scott Solomon

Angiotensin Receptor Neprilysin Inhibition for Heart Failure

19:45
Mount Sinai Advanced Heart Disease Symposium 2017

Pulmonary Hypertension: The Basic Essential Facts

Feat. M. Trivieri
17:23
Northwestern Medicine: 8th Annual Cardiovascular Update

AF and Heart Failure: What’s the Risk? Is Ablation the Answer?

Feat. J. Piccini
07:16
Novartis

The Importance of Physical Examination in Patients With Heart Failure

Feat. G. Ewald
17:22
Getinge

IABP case study in Advance Heart Failure

Feat. J. Estep
30:55
Scripps Health: 2019 Sixth Annual Clinical Advances in Heart Failure and Arrhythmias

Pulmonary Hypertension: My Patient has High PA Pressure on Echo, What Now?

Feat. T. Heywood
35:15
Scripps Health: Fourth Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

Pulmonary Arterial Hypertension: Who, When and How to Treat?

Feat. R. Mohan
36:06
37th Annual Advances in Heart Disease

SGLT2 Inhibitors for Heart Failure with or without Diabetes: What Are the …

Feat. J. Davis
17:01
16th Annual Heart Failure Holiday Symposium

Updates in Treatment Approaches to HFpEF: What Is the Phenotype-guided App…

Feat. S. Shah
22:43
Mount Sinai Advanced Heart Symposium 2016

Chronic Heart Failure Update: Incorporating Sacubatril / Valsartan and Iva…

Feat. S. Pinney
26:38
AACC American Association for Clinical Chemistry

Evaluation of Sex-Specific 99th Percentile URLs for hs-cTn Assays: Will th…

Feat. F. Apple